Jung, Ronja http://orcid.org/0000-0002-5611-2672
Kempf, Melanie
Holocher, Saskia
Kortüm, Friederike C.
Stingl, Krunoslav
Stingl, Katarina
Funding for this research was provided by:
Universitätsklinikum Tübingen
Article History
Received: 4 May 2023
Revised: 25 August 2023
Accepted: 8 September 2023
First Online: 28 September 2023
Declarations
:
: The study was approved by the ethics committee of the University of Tübingen. All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Tübingen and with the 1964 Helsinki declaration and its later amendments. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all participants included in the study.
: Katarina Stingl is a consultant for Novartis, ProQR, ViGeneron, Santen, and Janssen, with all fees paid to Center for Ophthalmology, University of Tübingen, to support the research. Friederike Kortüm is a consultant for Novartis. No conflicts of interest for this work.